Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.

Abstract

The neuropeptide PACAP (pituitary adenylate cyclase activating polypeptide) and its receptors are widely expressed in the nervous system including the retina. PACAP has well-known neuroprotective effects in neuronal cultures in vitro and against different insults in vivo. Recently, we have shown that PACAP1-38 is neuroprotective against monosodium glutamate (MSG)-induced retinal degeneration. Studying the molecular mechanisms of this protection has revealed that PACAP1-38 stimulates anti-apoptotic mechanisms such as phosphorylation of ERK1/2 and inhibits pro-apoptotic signaling molecules such as JNK1/2, p38MAPK, caspase-3 and the translocation of mitochondrial cytochrome c and apoptosis inducing factor in glutamate-treated retinas in vivo. In the present study we investigated the effects of PACAP1-38 on a further signal transduction pathway possibly involved in the protective effect of intravitreal PACAP1-38 administration against apoptotic retinal degeneration induced by neonatal MSG treatment. The focus of the present study was the protein kinase A (PKA)-Bad-14-3-3 transduction pathway. In vivo MSG treatment led to a reduction in the levels of anti-apoptotic molecules (phospho-PKA phospho-Bad, Bcl-xL and 14-3-3 proteins) in the retina. Co-treatment with PACAP1-38 counteracted these effects: the level of phospho-PKA, phospho-Bad, Bcl-xL and 14-3-3 were increased. All effects of PACAP1-38 were inhibited by the PACAP antagonist PACAP6-38. In summary, our results show that PACAP1-38 activates the PKA-Bad-14-3-3 pathway which is inhibited by MSG treatment. Our results also provide new insights into the signaling mechanisms possibly involved in the PACAP-mediated anti-apoptotic effects.

• Authors: Boglárka Rácz, Ferenc Gallyas Jr, Péter Kiss, Andrea Tamás, Andrea Lubics, István Lengvári, Erzsébet Röth, Gábor Tóth, Orsolya Hegyi, Zsófia Verzál, Csaba Fabricsek, Dóra Reglódi
• Journal: Neurotoxicity research (Neurotox Res) Vol. 12 Issue 2 Pg. 95-104 (Sep 2007) ISSN: 1029-8428 [Print] United States
• PMID: 17967733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• 14-3-3 Proteins
• Enzyme Inhibitors
• Pituitary Adenylate Cyclase-Activating Polypeptide
• bcl-Associated Death Protein
• Glutamic Acid
• Cyclic AMP-Dependent Protein Kinases

Topics

• 14-3-3 Proteins (metabolism)
• Animals
• Animals, Newborn
• Cyclic AMP-Dependent Protein Kinases (metabolism)
• Drug Interactions
• Enzyme Inhibitors (pharmacology)
• Glutamic Acid
• Models, Biological
• Pituitary Adenylate Cyclase-Activating Polypeptide (metabolism, pharmacology)
• Rats
• Rats, Wistar
• Retinal Diseases (chemically induced, metabolism)
• Signal Transduction (drug effects, physiology)
• bcl-Associated Death Protein (metabolism)